Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-21-000312
Filing Date
2021-05-19
Accepted
2021-05-19 14:25:16
Documents
2
Group Members
GILAD AHARONROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G phasebio_13g.htm SC 13G 107695
2 EXHIBIT A ex_a.htm EX-99.A 6397
  Complete submission text file 0001019056-21-000312.txt   115949
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Subject) CIK: 0001169245 (see all company filings)

EIN.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90691 | Film No.: 21939850
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8
Business Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: SC 13G